Delaware
|
85-1388175
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
Large accelerated filer ☐
|
|||
Non-accelerated filer ☒
|
Smaller reporting company ☒
|
||
Emerging growth company ☒
|
Title of Securities to be Registered
|
Amount
to be
Registered
(1)
|
Proposed
Maximum
Offering
Price
Per Share
|
Proposed
Maximum
Aggregate
Offering Price
(2)
|
Amount of
Registration
Fee
|
|||||||||||
Class A common stock, par value $0.0001 per share
|
25,241,575
|
(2)
|
|
$
|
192,776,661.75
|
$
|
21,031.93
|
(1) |
The number of shares of Class A common stock, par value $0.0001 per share (“Class A common stock”), stated above consists of the aggregate number of shares which may be sold upon the exercise of options or issuance of stock-based awards
which have been granted and/or may hereafter be granted under the 2021 Equity Incentive Plan (the “2021 Plan”) and the 2013 Employee, Director and Consultant Equity Incentive Plan, as amended (the “2013 Plan,” and collectively, the
“Plans”). The shares of Class A common stock registered hereunder for issuance pursuant to the 2021 Plan consist of up to 12,821,413 shares currently reserved for issuance pursuant to the 2021 Plan as well as up to 12,420,162 additional
shares which are currently issuable pursuant to awards granted under the 2013 Plan and which may become authorized for issuance under the 2021 Plan if awards outstanding under the 2013 Plan are cancelled or expire. Pursuant to Rule 416(a)
under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of the Registrant’s Class A common stock that become issuable under the Plans by reason of any stock
dividend, stock split, recapitalization or similar transaction effected without the Registrant’s receipt of consideration which would increase the number of outstanding shares of Class A common stock.
|
(2) |
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) and Rule 457(c) promulgated under the Securities Act. The offering price per share and the aggregate offering price for shares
reserved for future issuance under the Plans are based on (i) in the case of shares of Class A common stock which may be purchased upon exercise of outstanding options, the fee is calculated on the basis of the price at which the options
may be exercised; and (ii) in the case of shares of Class A common stock not yet issued and subject to stock-based awards or for which awards have not yet been granted, the average of the high and the low price of Registrant’s Class A
common stock as reported on the Nasdaq Stock Market on August 26, 2021. The chart below details the calculations of the registration fee:
|
Securities
|
Number of
Shares
|
Offering
Price Per
Share
|
Aggregate
Offering Price
|
||||||||||
Shares reserved for future issuance under the 2021 Plan
|
12,321,710
|
$
|
9.03
|
(2
|
)
|
$
|
111,265,041.30
|
||||||
Shares underlying option awards outstanding under the 2021 Plan
|
499,703
|
$
|
9.73
|
(2
|
)
|
$
|
4,862,110.19
|
||||||
Shares reserved for future issuance under the 2013 Plan
|
4,701,781
|
$
|
9.03
|
(2
|
)
|
$
|
42,457,082.43
|
||||||
Shares underlying option awards outstanding under the 2013 Plan
|
7,718,381
|
$
|
4.43
|
(2
|
)
|
$
|
34,192,427.83
|
||||||
Proposed Maximum Aggregate Offering Price
|
$
|
192,776,661.75
|
|||||||||||
Registration Fee
|
$
|
21,031.93
|
Item 3. |
Incorporation of Documents by Reference.
|
(a) |
The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Commission on March 30, 2021 as amended
by Amendment No. 1 to the Registrant’s Annual Report on Form 10-K/A for the year ended December 31, 2020, filed with the Commission on May
10, 2021;
|
(b) |
The prospectus filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act, on July 22, 2021,
relating to the Registration Statement on Form S-1, as amended (File No. 333- 257676), which contains the Registrant’s audited financial statements for the latest fiscal year for which such statements have been filed;
|
(c) |
The Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, filed with the Commission on May 24, 2021 as
amended by Amendment No. 1 to the Registrant’s Quarterly Report on Form 10-Q/A for the quarter ended March 31, 2021, filed with the Commission on June 10, 2021, and the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, filed with the Commission on August 16, 2021;
|
(c) |
The Registrant’s Current Reports on Form 8-K or 8-K/A as filed with the Commission on February 18, 2021, February 19, 2021,
February 23, 2021, May 10, 2021, June 8, 2021, June 9, 2021, June 15, 2021, June 16, 2021, June 24, 2021, June 25, 2021, and July 6, 2021; and
|
(d) |
The description of the Registrant’s securities contained in the Registrant’s registration statement on Form 8-A (File No. 001-39486), filed by the Registrant with the Commission
under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on September
2, 2020, including any amendments or reports filed for the purpose of updating such description.
|
Item 4. |
Description of Securities.
|
Item 5. |
Interests of Named Experts and Counsel.
|
Item 6. |
Indemnification of Directors and Officers.
|
Item 7.
|
Exemption from Registration Claimed.
|
Item 8.
|
Exhibits.
|
Exhibit
Number
|
Exhibit Description
|
Filed
Herewith
|
Incorporated
by
Reference
herein from Form or
Schedule
|
Filing Date
|
SEC File/
Reg.
Number
|
|||||
Second Amended and Restated Certificate of Incorporation of Quantum-Si Incorporated
|
Form 8-K
(Exhibit 3.1)
|
6/15/2021
|
001-39486
|
|||||||
Amended and Restated Bylaws of Quantum-Si Incorporated
|
Form 8-K
(Exhibit 3.2)
|
6/15/2021
|
001-39486
|
|||||||
Specimen Class A Common Stock Certificate
|
Form S-4/A
(Exhibit 4.1)
|
5/11/2021
|
333-253691
|
|||||||
Warrant Agreement, dated as of September 3, 2020, by and between Quantum-Si Incorporated (formerly HighCape Capital Acquisition Corp.) and Continental Stock Transfer & Trust Company
|
Form 8-K
(Exhibit 4.1)
|
9/9/2020
|
001-39486
|
|||||||
Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
|
X
|
|||||||||
Consent of WithumSmith+Brown, PC, independent registered public accounting firm of HighCape Capital Acquisition Corp.
|
X
|
|||||||||
Consent of Deloitte & Touche LLP, independent registered public accounting firm of Quantum-Si Incorporated
|
X
|
|||||||||
Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in Exhibit 5.1)
|
X
|
Power of Attorney (included on the signature page hereof)
|
X
|
|||||||||
Quantum-Si Incorporated 2021 Equity Incentive Plan
|
Form 8-K
(Exhibit 10.13.1)
|
6/15/2021
|
001-39486
|
|||||||
Form of Stock Option Agreement under 2021 Equity Incentive Plan
|
Form 8-K
(Exhibit 10.13.2)
|
6/15/2021
|
001-39486
|
|||||||
Form of Restricted Stock Unit Agreement under 2021 Equity Incentive Plan
|
X
|
|||||||||
Q-SI Operations Inc. 2013 Employee, Director and Consultant Equity Incentive Plan, as amended
|
Form 8-K
(Exhibit 10.14.1)
|
6/15/2021
|
001-39486
|
|||||||
Form of Stock Option Agreement under 2013 Employee, Director and Consultant Equity Incentive Plan, as amended
|
Form 8-K
(Exhibit 10.14.2)
|
6/15/2021
|
001-39486
|
|||||||
Form of Restricted Stock Unit Agreement under 2013 Employee, Director and Consultant Equity Incentive Plan, as amended
|
Form 8-K
(Exhibit 10.14.3)
|
6/15/2021
|
001-39486
|
Item 9. |
Undertakings.
|
(1) |
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
(i) |
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended;
|
(ii) |
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent
no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
|
(iii) |
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.
|
(2) |
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof.
|
(3) |
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
|
(4) |
That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements
relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness; provided, however, that no
statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of first use.
|
(5) |
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of
the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
|
(i) |
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
|
(ii) |
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;
|
(iii) |
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
|
(iv) |
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
|
QUANTUM-SI INCORPORATED
|
||
By:
|
/s/ John Stark
|
|
John Stark
|
||
Chief Executive Officer
|
Signature
|
Title
|
Date
|
||
/s/ John Stark
|
Chief Executive Officer and Director
(Principal Executive Officer)
|
September 2, 2021
|
||
John Stark
|
||||
/s/ Claudia Drayton
|
Chief Financial Officer (Principal Financial and Accounting Officer)
|
September 2, 2021
|
||
Claudia Drayton
|
||||
/s/ Jonathan M. Rothberg, Ph.D.
|
Executive Chairman
|
September 2, 2021
|
||
Jonathan M. Rothberg, Ph.D.
|
||||
/s/ Marijn Dekkers, Ph.D.
|
Director
|
September 2, 2021
|
||
Marijn Dekkers, Ph.D.
|
||||
/s/ Ruth Fattori
|
Director
|
September 2, 2021
|
||
Ruth Fattori
|
||||
/s/ Brigid A. Makes
|
Director
|
September 2, 2021
|
||
Brigid A. Makes
|
||||
/s/ Michael Mina, M.D., Ph.D.
|
Director
|
September 2, 2021
|
||
Michael Mina, M.D., Ph.D.
|
||||
/s/ Kevin Rakin
|
Director
|
September 2, 2021
|
||
Kevin Rakin
|
||||
/s/ James Tananbaum, M.D.
|
Director
|
September 2, 2021
|
||
James Tananbaum, M.D.
|
One Financial Center
Boston, MA 02111
617 542 6000
mintz.com
|
|
Very truly yours,
|
|
|
|
/s/ Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
|
/s/ WithumSmith+Brown, PC
|
|
New York, New York
|
|
September 2, 2021
|
/s/ Deloitte & Touche LLP
|
|
New York, New York
|
|
September 2, 2021
|
Vesting of Award:
|
This Restricted Stock Unit Award shall vest as follows provided the Participant is an Employee, director or Consultant of the Company or of an Affiliate on the applicable vesting date:
|
[Vesting Schedule Description]
|
QUANTUM-SI INCORPORATED
|
By:
|
Name:
|
|
Title:
|
|
Participant
|